|
 |
| |
|
|
08.30-09.00 |
LECTURE-1 |
Hall A |
| |
Chairpersons : Vidosava Nesic, Momir
Polenakovic, Ali Başcı |
| 08.30-08.50 |
Health is wealth. Is wealth also health?
Horst Klinkmann |
| 08.30-09.00 |
Discussion
|
| 09.00-10.00 |
ORAL PRESENTATIONS-1 |
Hall A |
| |
Chairpersons : Vidosava Nesic, Momir
Polenakovic, Ali Başcı
|
| OP-01 |
Aortic Calcification, Serum
Fetuin-A and Long-Term Mortality in Chronic Haemodialysis Patients
A. Papagianni, S. Dovas, C. Bantis, C. Dimitriadis, E. Zafeiriadou,
K. Tsinoglou, P. Pateinakis,
A. M. Belechri, G. Efstratiadis, D. Memmos |
| OP-02 |
N-Terminal Pro Brain
Natriuretic Peptide Predicts Mortality in Patients with End-Stage Renal
Disease in Hemodialysis
G. Selim, O. Stojceva Taneva, N. Stojcev, S. Gelev, A. Asani, P.
Dzekova Vidimliski, L. Trajcevska,
G. Severova Andeevska, V. Pusevski, A. Sikole |
| OP-03 |
Comparison of Different
Arterial Stiffness Parameters on Prediction of Mortality in Hemodialysis
Patients
M. Seziş Demirci, G. Aşçı, M. Kayıkçıoğlu, M. Özkahya, M. Ertilav, M.
Tanrısev, S. Erten, E. Ok |
| OP-04 |
QT Dispersion Predicts
Mortality and Correlates with Carotid Plaque Score but not with Coronary
Artery Calcification Score in Hemodialysis Patients
M. Güney, A. Özkök, Y. Çalışkan, H. Pusuroğlu, H. Yazıcı, S. Tepe, H.
Oflaz, A. Yıldız |
| OP-05 |
Comparison of Nutrition and
Inflammation Markers in Hemodialysis Patients with and without
Failed Renal Allografts
Y. Çalışkan, N. Görgülü, B. Yelken, A. Özkök, H. Yazıcı, A. Telci, A.
Yıldız, M. Ş. Sever |
| OP-06 |
Extracellular Fluid Volume
and Mortality in Hemodialysis
C. Demirci, M. Özkahya, M. Demirci, E. Hür, S. M. Adam, E. Ok, A.
Başçı, H. Töz |
| 09.00-10.00 |
ORAL PRESENTATIONS-2 |
| |
Chairpersons: Milan Radovic, Vesselin
Nenov
|
| OP-07 |
Peritoneal Ultrafiltration
for the Treatment of Severe Refractory Congestive Heart Failure at
Geriatric Patients
Ç. Ruhi, F. Ersoy, G. Süleymanlar, G. Yakupoğlu |
| OP-08 |
Clinical Outcome of Diabetic
Peritoneal Dialysis Patients: One Center Experience
A. Ünsal, Y. Koç, Ş. Köse, O. Akgün, M. Yılmaz, T. Sakacı, E. Ahbap,
A. Sinangil Arar |
| OP-09 |
Interleukin-6 is a Strong
and Independent Predictor of the Extent and Severity of Vascular
Atherosclerotic Lesions in Peritoneal Dialysis Patients
C. Dimitriadis, A. Papagianni, K. Tsinoglou, P. Pateinakis, A.
Tsiantoulas, G. Efstratiadis,
E. Kokolina, D. Memmos |
| OP-10 |
Evaluation of Anuric versus
Non-Anuric 127 Peritoneal Dialysis Patients
E. Ahbap, A. Ünsal, Y. Koç, M. Yılmaz, T. Sakacı, O. Akgün, Ş. Köse |
| OP-11 |
Comparison of Aminoacids
Containing Dialysate, Oral Essential Aminoacids and Dialysate
Plus Oral Aminoacids Treatments for Improvement of Nutritional Status in
Peritoneal Dialysis
Patients
S. Ünverdi, E. Uz , M. Çeri, M. Altay, Y. Kıraç, H. Parpucu, M.
Duranay |
| OP-12 |
Aldosterone Inhibition may
Reverse Encapsulated Peritoneal Sclerosis
D. Bozkurt, H. Taşkın, Ö. Timur, M. Özışık, A. Erden, B. Sarsık, A.
Başçı, S. Duman |
| 10.00-10.30 |
Coffee Break |
|
| |
|
|
|
10.30-11.30 |
PANEL-1 |
Hall A |
| |
Chairpersons: Dimitar Nenov, Kamil
Serdengeçti |
|
| 10.30-10.55 |
Multiple benefits of screening for CKD
Ljubica Djukanovic |
|
| 10.55-11.20 |
Hypertension in ESRD
Carmine Zoccali |
|
| 11.20-11.30 |
Discussion
|
|
|
10.30-11.30 |
PANEL-2 |
Hall 3 |
| |
Chairpersons : Adrian C. Covic, Itır
Yeğenağa |
|
| 10.30-10.55 |
Is chronic hemodialysis really so inferior
to kidney transplantation?
Jadranka P-Buturovic |
| 10.55-11.20 |
Achilles' Heel in hemodialysis: Vascular
access
Mehmet Şükrü Sever |
| 11.20-11.30 |
Discussion
|
|
| 11.30-12.30 |
SATELLITE SYMPOSIUM |
 |
Hall A |
| |
Chairperson: Goce Spasovski |
|
| 11.30-12.00 |
Management of phosphate and cardiovascular
risks in CKD
Mihai Voiculescu |
| 12.00-12.30 |
Improving clinical outcomes in CKD-MBD
Goce Spasovski
|
|
| 12.30-13.30 |
Lunch |
(Main
Restaurant) |
| |
|
|
| 12.30-13.30 |
9th BANTAO CONGRESS POSTER DISCUSSIONS-1 |
Poster Area |
| |
Chairpersons: Veselin
Nenov, Şehsuvar Ertürk, Gülay Aşçı
PP-001 - PP-022 |
| |
Chairpersons: Gabriel
Papadakis, Cem Sungur, Belda Dursun
PP-023 - PP-047 |
| |
Chairpersons: George
Vergoulas, Serhan Tuğlular, Gülçin Kantarcı
PP-048 - PP-065 |
| |
Chairpersons: Gabriel
Mircescu, Neslihan Seyrek, Mahmut İlker Yılmaz
PP-066 - PP-086 |
| 13.30-14.30 |
SATELLITE SYMPOSIUM |
 |
Hall A |
| |
20 YEARS OF BRINGING BETTER LIFE TO
RENAL PATIENTS |
| |
Chairperson: Carmine Zoccali |
|
| 13.30-13.45 |
Anemia and CKD: A long journey in the
nephrology territory
Carmine Zoccali |
| 13.45.14.00 |
Recombinant human erythropoietin vs.
Modified erythropoiesis stimulating agents: facts and hypotheses
Vladimir Trkulja |
| 14.00-14.15 |
Biosimilars: Why do we need guidelines?
Nada Dimkovic |
|
| 14.15-14.30 |
From vascular access for hemodialysis to
complete care of renal patients, provided by nephrologists
Rafael Ponikvar
|
|
14.30-15.30 |
PANEL-3 |
Hall A |
| |
Chairpersons: Dimitris Tsakiris,
Yunus Erdem |
|
| 14.30-14.45 |
Diabetic nephropathy: Early diagnosis and
options for treatment
Momir Polenakovic |
| 14.45-15.00 |
New onset diabetes after kidney
transplantation
Hüseyin Töz |
| 15.00-15.15 |
Diabetes and hypertension
Myftar Barbullushi |
|
| 15-15-15.30 |
Discussion
|
|
|
14.30-15.30 |
LECTURE-2 |
Hall 3 |
| |
Chairpersons: Dimitrios
G. Oreopoulos, Cengiz Utaş |
|
| 14.30-14.55 |
Home dialysis first: A
new paradigm for new ESRD patients
Dimitrios G. Oreopoulos |
| 14.55-15.20 |
Preservation of residual
renal function in dialysis (PD-HD)
Hülya Taşkapan |
| 15.20-15.30 |
Discussion
|
|
| 15.30-16.00 |
Coffee
Break |
|
| |
|
|
| 16.00-17.00 |
PANEL-4
|
Hall A |
| |
RENAL BONE DISEASE |
|
| |
Chairpersons: Dimitirios
Memmos, Enver Hasanoğlu |
|
| 16.00-16.15 |
Adynamic bone disease
Ploumis Passadakis |
|
| 16.15-16.30 |
Hyperparathyroidism
Serhan Tuğlular |
|
| 16.30-16.45 |
Brown tumor associated
with secondary hyperparathyroidism in hemodialysis patients
Halima Resic |
| 16.45-17.00 |
Discussion
|
|
| 16.00-17.00 |
PANEL-5 |
Hall 3 |
| |
Chairpersons:
Constantinos Stefanidis, Nejat Aksu |
|
| 16.00-16.25 |
Henoch-Schonlein purpura
nephritis in children: Risk factors, prevention and treatment
Radovan Bogdanovic |
| 16.25-16.50 |
Target therapies in
glomerular diseases: The example of B-cell depletion in membranous
nephropathy John Boletis |
| 16.50-17.00 |
Discussion
|
|
| 17.00-18.00 |
LECTURE & ORAL
PRESENTATIONS-3 |
Hall 4 |
| |
Chairpersons: Petar Kes,
Georgios Vergoulas |
|
| 17.00-17.15 |
Focal glomerulosclerosis (FSGS)
Dimitrios Goumenos
|
|
| 17.15-18:00 |
Oral Presentations-3 |
|
| OP-13 |
DKD in Patients with
Diabetes Type 2 in Ukraine
D. Ivanov, B. Mankovskiy |
| OP-14 |
Genetic and Non-Genetic Type
of Steroid-Resistant Nephrotic Syndrome and Cyclosporine A
Response
F. Mutlubaş, S. Mir, A. Berdeli |
| OP-15 |
Low Dose Multitarget Therapy
in Older Patients with ANCA Vasculitis
S. Marinaki, C. Skalioti, M. Darema, P. Papadaki, A. Iniotaki, I. N.
Boletis |
| OP-16 |
Alpha-Galactosidase A
Deficiency in Turkish Male Hemodialysis Patients
S. Kalkan Uçar, E. Sözmen, S. Duman, A. Başcı, M. Coker |
| OP-17 |
New Insights in
Glomeronephritis: How Erythrocytes Transform to Acanthocytes
H. Eggers, H. U. Gutsche - (This abstract has been withdrawn by the authors) |
| 17.00-18.00 |
LECTURE & ORAL
PRESENTATIONS-4 |
Hall 5 |
| |
Chairpersons: Gabriel
Mircescu, Şükrü Ulusoy |
|
| 17.00-17.15 |
Inflammation in acute kidney injury
Belda Dursun
|
|
| 17.15-18:00 |
Oral Presentations-4 |
|
| OP-18 |
Correlation between Clinical
and Laboratory Parameters and Tubular and Interstitial Changes in
Patients with Chronic Glomerulonephritis
B. P. Deliyska, V. I. Tzeneva, V. L. Shurliev, V. I. Lazarov, V. V.
Vasilev, H. P. Shivarov |
| OP-19 |
Risk Factors for Renal
Biopsy Complications
M. L. Doncheva, B. I. Bogov, R. J. Djerassi, B. N. Kiperova |
| OP-20 |
Severity and Outcome of
Acute Kidney Injury According to RIFLE Criteria in the Intensive Care
Unit
A. Gjyzari, N. Thereska, M. Barbullushi, A. Koroshi, S. Kodra, E.
Petrela, A. Idrizi, A. Strakosha |
| OP-21 |
Epidemiology of Infection in
Critically ill Patients with Sepsis/SIRS and Its Influence on Acute
Kidney Injury
I. Yeğenağa, S. Keçeli Özcan, M. Meriç, N. Baykara, K. Toker |
| OP-22 |
Upper UEM Associated with &
without BEN - Possible Dissociation of AA Toxic & Mutagenic
Effects in Endemic Regions
M. Savin, J. Dimitrijevic, I. Maric, V. Bumbasirevic |
| 19.00-20.30 |
OPENING
CEREMONY |
Hall 1 |
| |
| 20.30 |
WELCOME RECEPTION
 |
Hall 2&3 |
| |
Invitation
Congress at a Glance
